<?xml version="1.0" encoding="UTF-8"?>
<p id="para0045">In addition, researchers need to know whether the vaccine will induce the same type of immune system failures that have been observed previously. In some cases, the vaccine-primed immune system seems to initiate a shoddy response to natural infections 
 <xref rid="bib0137" ref-type="bibr">[137]</xref>. Additionally, allergic inflammation aroused by Th2 immunopathology should be taken into consideration, according to theCoV experts 
 <xref rid="bib0137" ref-type="bibr">[137]</xref>. Therefore, animal and human clinical trials of COVID-19 candidate vaccines should encompass a rigorous assessment of possible immune complications before putting into use.
</p>
